Cargando…

NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity

Natural killer (NK) cells, key effector cells of the innate immune system, play an important role in the clearance and control of Mycobacterium tuberculosis and HIV infections. Here, we utilized peripheral blood specimens from the Improving Retreatment Success CAPRISA 011 study to characterize NK ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maseko, Thando Glory, Rambaran, Santhuri, Ngubane, Slindile, Lewis, Lara, Ngcapu, Sinaye, Hassan-Moosa, Razia, Archary, Derseree, Perumal, Rubeshan, Padayatchi, Nesri, Naidoo, Kogieleum, Sivro, Aida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359304/ https://www.ncbi.nlm.nih.gov/pubmed/37474556 http://dx.doi.org/10.1038/s41598-023-38766-7

Ejemplares similares

Higher plasma interleukin − 6 levels are associated with lung cavitation in drug-resistant tuberculosis
por: Maseko, Thando Glory, et al.
Publicado: (2023)

Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection
por: Rambaran, Santhuri, et al.
Publicado: (2023)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa
por: Rambaran, Santhuri, et al.
Publicado: (2021)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
por: Dookie, Navisha, et al.
Publicado: (2018)

The whole is greater than the sum of the parts: Recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2009)

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2014)

Quality of TB care among people living with HIV: Gaps and solutions
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
por: Naidoo, Anushka, et al.
Publicado: (2022)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Advances in tuberculosis control during the past decade
por: Naidoo, Kogieleum, et al.
Publicado: (2023)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

A Quality Improvement Intervention to Inform Scale-Up of Integrated HIV-TB Services: Lessons Learned From KwaZulu-Natal, South Africa
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
por: Lale Ngema, Senamile, et al.
Publicado: (2023)

Mandatory COVID-19 Vaccination: Lessons from Tuberculosis and HIV
por: Mtimkulu-Eyde, Lynette, et al.
Publicado: (2022)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
por: Dookie, Navisha, et al.
Publicado: (2022)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
por: Naidoo, Anushka, et al.
Publicado: (2017)

Metformin as Host-Directed Therapy for TB Treatment: Scoping Review
por: Naicker, Nikita, et al.
Publicado: (2020)

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
por: Chimukangara, Benjamin, et al.
Publicado: (2020)

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists
por: Shey, Muki S., et al.
Publicado: (2016)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis
por: Nandlal, Louansha, et al.
Publicado: (2022)

Long COVID: An approach to clinical assessment and management in primary care
por: Perumal, Rubeshan, et al.
Publicado: (2023)

Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes
por: Loveday, Marian, et al.
Publicado: (2014)

Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa
por: Padayatchi, Nesri, et al.
Publicado: (2019)

Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa
por: Tomita, Andrew, et al.
Publicado: (2019)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa( )
por: Samsunder, Natasha, et al.
Publicado: (2022)

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
por: Naicker, Nikita, et al.
Publicado: (2023)

Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets
por: Qulu, Wenkosi Perez, et al.
Publicado: (2023)

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing
por: Dookie, Navisha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jb9nvn6etjibccc0u2fr2k9ft0